Article

Patient Experience With CLL Not Widely Discussed

Cancer Support Community tackles the CLL experience in new cancer experience registry.

WASHINGTON - (May 26, 2015) - The Cancer Support Community (CSC), an international nonprofit dedicated to providing support, education and hope to people impacted by cancer, announced today a new Registry specifically for people with chronic lymphocytic leukemia (CLL). This addition to CSC's Cancer Experience Registry will explore details regarding the treatment, management and perceptions surrounding a cancer that will impact over 106,000 people in the U.S. this year.

"We are pleased the reach of the Cancer Experience Registry is expanding." said Kim Thiboldeaux, CEO of the Cancer Support Community. "The data gathered from this new Registry will shed light on the full impact of CLL, while providing a support network for people living with this disease."

"We're proud to sponsor the development of this Registry and applaud CSC for this initiative," said Cindy Guzzo, Vice President of Medical Affairs at Janssen Biotech. "While CLL is one of the most common blood cancers, it is still considered a rare disease, which means the information gathered in the Registry is extremely important."

The Cancer Support Community introduced the Cancer Experience Registry as a way to give a voice to people living with cancer and to convey the specific emotional, financial and social impacts of living with cancer to the cancer community at large. The CLL Registry is the ninth in a series of specialty Registries reaching into specific cancer types. In addition to the Cancer Experience Registry which is open to anyone with any type of cancer, there are Registries for patients with breast cancer, metastatic breast cancer, multiple myeloma, chronic myeloid leukemia, lung cancer and melanoma. Caregivers are also invited to participate by joining the Cancer Experience Registry: Caregivers and Multiple Myeloma Caregivers.

"Registries provide important information about the natural history of a disease and help clinicians better understand how to appropriately treat patients," said Elizabeth Faust, Ph.D., Head of Medical Affairs at Pharmacyclics. "We believe that the insights gathered from this CLL-focused Registry will enhance CLL treatment."

The Cancer Experience Registry: Chronic Lymphocytic Leukemia is made possible thanks to a generous sponsorship from Janssen Biotech, Inc. and Pharmacyclics.

www.CancerExperienceRegistry.org

For more information on the Cancer Experience Registry: CLL and Cancer Experience Registry: Caregivers, please visit .

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of man with text.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Image of man with text.
Image of women, with text.
Image of Dr. with text.
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Related Content
Image of women.
July 10th 2025

Diagnosis Day: What I Felt, What I Learned

Patti McGee
I found a lump and was shocked to learn it was breast cancer, but over 22 years I’ve learned healing takes time, asking for help is strength, and hope grows.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Kim Johnson was a caregiver for her sister while she battled stage 4 Hodgkin Lymphoma for nearly five years, from diagnosis through an autologous transplant. Catch up on all of Kim's blogs here!
July 10th 2025

Saying Goodbye to My Sister With Hodgkin Lymphoma

Kim Johnson
After nearly 11 years of living with Hodgkin lymphoma, my sister Kathleen passed away peacefully at 39, leaving me to navigate the sorrow of losing her.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Image of lungs.
July 10th 2025

FDA OKs New Test to Match Lung Cancer Patients With Targeted Therapies

Ryan Scott
The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment called Zegfrovy.
Breast cancer care differs around the world, revealing urgent unmet needs: © stock.adobe.com.
July 9th 2025

Layers of Pain: Decoding the Multifaceted Toxicity of Breast Cancer

Dr. Dinesh Raj Neupane
Breast cancer care differs around the world, revealing urgent unmet needs in Nepal, where access, support, and treatment remain out of reach for many.